What is the significance of MSSA or MRSE with a vancomycin MIC of 2.0 mg/l? Was there enough data to support the area under the curve/MIC target and inferred troughs recommended in the guidelines?
Hosted on MSN11mon
Baxter's (BAX) New Injectables Aid Its Pharmaceutical PortfolioVancomycin injection, USP in 5% Dextrose with strengths of 1.25 g/250 mL and 1.5 g/300 mL are the first 250 mL and 300 mL frozen ready-to-use products that Baxter has launched. Vancomycin is ...
A retrospective study was conducted with adult inpatients over age 18 years who were initiated on vancomycin between August 1 and September 30, 2006 (preimplementation group), and between March 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results